"USA Mitchell Cancer Institute is providing exceptional care for cancer patients through innovative treatment and clinical research."

During the past decade, University of South Alabama Cancer Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of South Alabama Cancer Research Institute" #1 sponsor was "Children's Oncology Group" with 12 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Alabama Cancer Research Institute" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of South Alabama Cancer Research Institute" are "Leukemia" (5 trials), "Sarcoma" (3 trials), "Neuroblastoma" (2 trials), "Prostatic Neoplasms" (2 trials) and "Brain and Central Nervous System Tumors" (1 trials). Many other conditions were trialed in "University of South Alabama Cancer Research Institute" in a lesser frequency.

Most popular intervention types in "University of South Alabama Cancer Research Institute" are "Drug" (16 trials), "Biological" (8 trials), "Radiation" (6 trials), "Procedure" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "filgrastim" (5 trials), "radiation therapy" (5 trials), "vincristine sulfate" (5 trials) and "conventional surgery" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of South Alabama Cancer Research Institute" are 16 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of South Alabama Cancer Research Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in University of South Alabama Cancer Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of South Alabama Cancer Research Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".